ANT Neuro

Executive Summary

ANT Neuro is a Dutch diagnostics company specializing in high-density EEG systems (8-256 channels) and neuronavigation for TMS and focused ultrasound. Founded in 1997 and based in Enschede, the company serves clinical and research markets, including sleep studies, brain-computer interfaces, and VR EEG. Its products enable advanced neuroscience studies and clinical neurology applications. Despite limited public financial data, ANT Neuro's longevity and focus on niche neurodiagnostics position it as a specialized player in the growing neurotechnology market, competing against larger firms through high-density configurations and integrated navigation solutions. The company's established reputation and product diversification support steady demand from academic and medical customers.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation high-density EEG system70% success
• Q2 2026Major research partnership for BCI applications with a top-tier university60% success
• Q4 2026Expansion into Asia-Pacific via exclusive distributor agreement50% success